Health care stocks declined late Monday afternoon, with the NYSE Health Care Index down 1.1% and the Health Care Select Sector SPDR Fund (XLV) falling 1.2%.
The iShares Biotechnology ETF (IBB) rose 0.6%.
In corporate news, Emergent BioSolutions (EBS) shares jumped 4.7% after the Biomedical Advanced Research and Development Authority awarded a $50 million option to the company's existing contract for the purchase of Cyfendus.
Aspira Women's Health (AWH) shares were fractionally up after it said Monday that Chief Executive Nicole Sandford will leave the company due to a family health matter, effective immediately. President Sandra Milligan will serve as interim CEO while the company searches for a permanent successor, the company said.
President-elect Donald Trump told reporters his administration is going to "knock out" pharmacy benefit managers to bring down drug prices, Bloomberg reported. Shares of CVS Health (CVS), UnitedHealth (UNH), and Cigna (CI), which own the three largest pharmacy benefit managers, fell 5.6%, 4.5%, and 3.2% respectively.
Maia Biotechnology (MAIA) shares jumped over 8% after the firm said its investigational telomere-targeting agent THIO received a rare pediatric disease designation from the US Food and Drug Administration to treat pediatric-type diffuse high-grade gliomas.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。